ODILE BELZUNCE

About ODILE BELZUNCE

Odile Belzunce is Vice President, Compliance & Operations at Innate Pharma, where she was appointed to the Executive Committee in January 2019. She joined Innate Pharma in February 2005 and has built a long-standing career within the Marseille-based, publicly listed biotechnology company focused on immuno-oncology. Her internal progression reflects steady advancement through key quality and compliance responsibilities: she served as Quality Manager for 10 years before becoming Head of Compliance. This path highlights deep expertise in the regulated environment of life sciences companies, especially in areas where operational discipline, quality systems, and governance are critical. Across her tenure at Innate Pharma, Belzunce contributed to structuring the company’s processes as the organization expanded its portfolio and activities. In a biopharmaceutical company, that means helping ensure that internal procedures keep pace with scientific development, regulatory expectations, and operational growth. Her responsibilities later evolved beyond compliance to include operations, and company materials also reference broader leadership responsibilities across IT and portfolio management as the management structure developed over time. This makes her a central figure in the company’s operational backbone rather than a publicly prominent commercial or research-facing executive. Her professional expertise sits at the intersection of quality assurance, compliance, process design, and operational governance—functions that are especially important for a biotech listed in France and in the United States. Rather than being known for headline-grabbing transactions, her contribution is more structural and strategic: strengthening the organizational framework that supports clinical development, partner interactions, and corporate growth. In that sense, Odile Belzunce can be viewed as a key executive in building the internal rigor and scalability needed for Innate Pharma’s continued development.